The miR-200 family in ovarian cancer
Metrics: PDF 2314 views | HTML 3180 views | ?
Maria Koutsaki1, Massimo Libra2, Demetrios A. Spandidos3 and Apostolos Zaravinos4
13rd Department of Pediatrics of the National and Kapodistrian University of Athens, Attikon University Hospital, 12462 Athens, Greece
2Department of Biomedical and Biotechnological Sciences, Laboratory of Translational Oncology and Functional Genomics, Section of General and Clinical Pathology and Oncology, University of Catania, 95124 Catania, Italy
3Laboratory of Virology, Medical School, University of Crete, 71110 Heraklion, Crete, Greece
4Department of Life Sciences, School of Sciences, European University Cyprus, 1516 Nicosia, Cyprus
Apostolos Zaravinos, email: [email protected]
Keywords: miR-200 family, ovarian cancer, prognosis, disease stage, tumor histology
Received: December 06, 2016 Accepted: May 22, 2017 Published: June 02, 2017
Ovarian cancer (OC) is the most lethal gynecological malignancy. Its insidious nature, manifesting with little to no symptoms until the disease progresses to metastasis, along with a wide diversity of histological subtypes and corresponding clinical behavior, poses significant therapeutic challenges. The genetic profiling of this aggressive tumor and its subtypes has led to the identification of various molecular markers of prognosis. Among these, the miR-200 family of miRNAs appears to play an important role. The deregulated expression of the miR-200 family members has been detected in a variety of OC studies. The present review examines the potential usefulness of the miR-200 family members as prognostic indicators in ovarian cancer and their impact across different OC publications, with a particular focus on prognostic features, such as disease stage, tumor histology, survival and response to chemotherapy. We present the potential usefulness of the miR-200 family genes as prognostic indicators in OC and highlight the tendency that miR-200 overexpression corresponds with an advanced cancer stage.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.